Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katherine A Alser"'
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147233 (2016)
The need for more effective anti-chlamydial therapeutics has sparked research efforts geared toward further understanding chlamydial pathogenesis mechanisms. Recent studies have implicated the secreted chlamydial serine protease, chlamydial protease-
Externí odkaz:
https://doaj.org/article/542a5ff0129d430aad3eb96d52dfcbb5
Publikováno v:
The Journal of Physical Chemistry B. 118:4514-4526
The abundance of α-fetoprotein (AFP), a natural protein produced by the fetal yolk sac during pregnancy, correlates with lower incidence of estrogen receptor positive (ER+) breast cancer. The pharmacophore region of AFP has been narrowed down to a f
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0147233 (2016)
PLoS ONE, Vol 11, Iss 2, p e0147233 (2016)
The need for more effective anti-chlamydial therapeutics has sparked research efforts geared toward further understanding chlamydial pathogenesis mechanisms. Recent studies have implicated the secreted chlamydial serine protease, chlamydial protease-
Autor:
Katrina W. Lexa, Leroy C. Joseph, Katherine A. Alser, James A. Bennett, Herbert I. Jacobson, Amanda M. Salisburg, George C. Shields, Karl N. Kirschner, Thomas T. Andersen
Publikováno v:
Journal of the American Chemical Society. 129:6263-6268
Breast cancer is the most common cancer among women, and tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment. Many of these cancers are intrinsically resistant to tamoxifen or acquire resistance during treatment. Co
Autor:
George C. Shields, Lorena Hernandez, Katrina W. Lexa, Karl N. Kirschner, Steven Feldgus, Damien J. Ellens, Jennifer R. Derby, Katherine A. Alser, Amanda M. Salisburg, Heather C. Michael, Sam J. Bono, Jaime G. Skiba
Publikováno v:
International Journal of Quantum Chemistry. 107:3001-3012
Breast cancer is the most common cancer among women. Tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment, yet many of these cancers are intrinsically resistant to tamoxifen or acquire resistance during treatment. Th